Results 181 to 190 of about 27,826 (225)
Some of the next articles are maybe not open access.
Biochemical and Biophysical Research Communications, 2007
The cholesterol 24-hydroxylase encoded by the gene CYP46 is expressed almost exclusively in central nervous system (CNS) neurons and catalyzes the formation of 24S-hydroxycholesterol (24S-OHC) from cholesterol. This conversion corresponds to a major pathway for excretion of excess cholesterol from the brain.
D, Famer +5 more
openaire +2 more sources
The cholesterol 24-hydroxylase encoded by the gene CYP46 is expressed almost exclusively in central nervous system (CNS) neurons and catalyzes the formation of 24S-hydroxycholesterol (24S-OHC) from cholesterol. This conversion corresponds to a major pathway for excretion of excess cholesterol from the brain.
D, Famer +5 more
openaire +2 more sources
The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
Progress in Neurobiology, 2015Proteins belonging to the 'A Disintegrin And Metalloproteinase' (ADAM) family are membrane-anchored proteases that are able to cleave the extracellular domains of several membrane-bound proteins in a process known as 'ectodomain shedding'. In the central nervous system, ADAM10 has attracted the most attention, since it was described as the amyloid ...
Saftig, Paul, Lichtenthaler, Stefan
openaire +2 more sources
α-Secretase Activation – An Approach to Alzheimer’s Disease Therapy
Neurodegenerative Diseases, 2006The nonamyloidogenic pathway of processing the amyloid precursor protein (APP) involves the cleavage within the amyloid-β peptide sequence, and thus precludes amyloid-β formation. The identification of a member of the disintegrin and metalloproteinase family, ADAM10, as an α-secretase that prevents plaque formation and hippocampal deficits in vivo gave
Falk, Fahrenholz, Rolf, Postina
openaire +2 more sources
ADAMs family members as amyloid precursor protein α‐secretases
Journal of Neuroscience Research, 2003AbstractIn the non‐amyloidogenic pathway, the Alzheimer's amyloid precursor protein (APP) is cleaved within the amyloid‐β domain by α‐secretase precluding deposition of intact amyloid‐β peptide. The large ectodomain released from the cell surface by the action of α‐secretase has several neuroprotective properties.
Allinson, Tobias M. J. +3 more
openaire +2 more sources
Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.
Neuroreport, 2002The amyloid cascade hypothesis suggests that amyloid precursor protein (APP) proteolytic processing is a key event in the pathogenesis of Alzheimer's disease (AD). The enzymes beta-site APP cleaving enzyme (BACE) and A disintegrin and metalloproteinase 10 (ADAM10) play an important role in APP proteolysis.
GATTA LB +3 more
openaire +2 more sources
International journal of molecular medicine, 2004
Abeta is the major component of amyloid in the brain in Alzheimer's disease and is derived from an amyloid precursor protein (APP) by the sequential proteolytic processing of two putative proteases, called beta- and gamma-secretase. To clarify the mechanism of gamma-secretase processing, we created constructs contained the C-terminal domain of APP and ...
Hideaki, Kume +3 more
openaire +1 more source
Abeta is the major component of amyloid in the brain in Alzheimer's disease and is derived from an amyloid precursor protein (APP) by the sequential proteolytic processing of two putative proteases, called beta- and gamma-secretase. To clarify the mechanism of gamma-secretase processing, we created constructs contained the C-terminal domain of APP and ...
Hideaki, Kume +3 more
openaire +1 more source
Iron Levels Modulate α‐Secretase Cleavage of Amyloid Precursor Protein
Journal of Neurochemistry, 1995Abstract: The amyloid precursor protein (APP) is a membrane‐spanning glycoprotein that is the source of βA4 peptides, which aggregate in Alzheimer's disease to form senile plaques. APP is cleaved within the βA4 sequence to release a soluble N‐terminal derivative (APPsol), which has a wide range of trophic and protective functions.
S, Bodovitz +3 more
openaire +2 more sources
Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase
Biochemical and Biophysical Research Communications, 2003The putative alpha-secretase cleaves the amyloid precursor protein (APP) of Alzheimer's disease in the middle of the amyloid beta peptide (Abeta) domain. It is generally thought that the alpha-secretase pathway mitigates Abeta formation in the normal brain.
Masashi, Asai +6 more
openaire +2 more sources
Journal of Alzheimer's Disease, 2006
Development of therapeutics begins with delineating the precise disease pathology along with a reasonable understanding of the sequence of events responsible for the development of disease, or disease pathogenesis. For Alzheimer's disease (AD), the classical pathology is now known for quite some time; however, the disease pathogenesis has eluded our ...
Van Broeckhoven, Christine +1 more
openaire +3 more sources
Development of therapeutics begins with delineating the precise disease pathology along with a reasonable understanding of the sequence of events responsible for the development of disease, or disease pathogenesis. For Alzheimer's disease (AD), the classical pathology is now known for quite some time; however, the disease pathogenesis has eluded our ...
Van Broeckhoven, Christine +1 more
openaire +3 more sources
Cryptotanshinione upregulates α-secretase by activation PI3K pathway in cortical neurons
Brain Research, 2010The amyloid precursor protein (APP) is cleaved enzymatically by nonamyloidogenic and amyloidogenic pathways. alpha-Secretase cleaves APP within beta amyloid protein (Abeta) sequence, resulting in the release of a secreted fragment of APP (sAPPalpha) and precluding Abeta generation.
Zhengrong, Mei +6 more
openaire +2 more sources

